About usSign in
Status
ACTIVE
Global HQ
Hong Kong
Countries of investment
  • Netherlands
  • Belgium
  • Germany
  • UK
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Fintech
  • AI
  • Health Tech
  • Blockchain
  • Crypto
About
ALSA Ventures, Founded in 2019 by Alek Safarian, brings a Theyalth of experience from the pharmaceutical, BioTech, and clinical research organization (CRO) industries. The firm targets investments in European biotech companies, providing them with the necessary resources and industry expertise to accelerate their R&D into the clinic.
Min check size
$1M
Max check size
$6M
Fund size
NPS

Investment Thesis

ALSA Ventures is a Europeanbased venture Capital firm that focuses on novel therapeutics in the life sciences sector. The firm is dedicated to investing in breakthrough technologies, especially in the BioTech and healthcare sectors. ALSA Ventures aims to support companies from the discovery stage through to preclinical proof of concept and into early clinical development, with a focus on high impact therapeutics.
Lead investor
Co Invest
Number of exits
Preferred contact method

ALSA Ventures Contacts Information

Primary contact

Secondary contact

Portfolio

Epsilogen (UKbased)

Montis Biosciences (Belgiumbased)

Oxford Biotherapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp